Tech Entrepreneur Steve Kirsch Tweets Unspecified Link Amidst Ongoing Vaccine Safety Debates

Image for Tech Entrepreneur Steve Kirsch Tweets Unspecified Link Amidst Ongoing Vaccine Safety Debates

Steve Kirsch, a prominent tech entrepreneur and vocal critic of COVID-19 vaccine safety, recently shared a tweet featuring a t.co short link, stating simply, "See: https://t.co/hKvdYQHdI4." The specific content behind the shortened URL could not be immediately determined. Kirsch, known for his prolific online presence, frequently uses platforms like Substack to disseminate his views on vaccine efficacy, alleged government corruption, and censorship.

Kirsch's public statements often challenge mainstream scientific consensus regarding COVID-19 vaccines. He claims to have authored over 1,700 articles on his Substack, asserting that COVID vaccines have no benefit and are responsible for a significant number of deaths in the United States. These claims have been widely disputed by fact-checking organizations and medical experts who cite robust data supporting vaccine safety and effectiveness.

His advocacy began with the COVID-19 Early Treatment Fund (CETF), which he founded in April 2020 to research off-label treatments. However, his tenure became controversial when he promoted unproven treatments and made unsubstantiated claims about vaccine dangers, leading to the resignation of CETF's scientific advisory board members. In September 2021, Kirsch founded the Vaccine Safety Research Foundation (VSRF), continuing to publish and promote content questioning vaccine safety.

Fact-checkers, including FactCheck.org and Reuters, have consistently debunked many of Kirsch's assertions, such as claims that vaccines "kill twice as many as they save" or that they cause widespread adverse events. Scientific bodies, including the FDA, have described his statements as "not based in science." Despite widespread refutation, Kirsch maintains a significant following on social media and his Substack platform, where he continues to share content related to his perspectives on public health issues.